NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Ignacio Garrido-Laguna, Jean L. Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith & 16 others Jeffrey Meyerhardt, Eric D. Miller, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass

Research output: Contribution to journalComment/debate

32 Citations (Scopus)

Abstract

The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.

Original languageEnglish (US)
Pages (from-to)359-369
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Colonic Neoplasms
Guidelines
Colorectal Neoplasms
Therapeutics
Survival Rate
Mutation
PLX4032

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y. J., Ciombor, K. K., ... Freedman-Cass, D. A. (2018). NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines JNCCN Journal of the National Comprehensive Cancer Network, 16(4), 359-369. https://doi.org/10.6004/jnccn.2018.0021

NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines . / Benson, Al B.; Venook, Alan P.; Al-Hawary, Mahmoud M.; Cederquist, Lynette; Chen, Yi Jen; Ciombor, Kristen K.; Cohen, Stacey; Cooper, Harry S.; Deming, Dustin; Engstrom, Paul F.; Garrido-Laguna, Ignacio; Grem, Jean L.; Grothey, Axel; Hochster, Howard S.; Hoffe, Sarah; Hunt, Steven; Kamel, Ahmed; Kirilcuk, Natalie; Krishnamurthi, Smitha; Messersmith, Wells A.; Meyerhardt, Jeffrey; Miller, Eric D.; Mulcahy, Mary F.; Murphy, James D.; Nurkin, Steven; Saltz, Leonard; Sharma, Sunil; Shibata, David; Skibber, John M.; Sofocleous, Constantinos T.; Stoffel, Elena M.; Stotsky-Himelfarb, Eden; Willett, Christopher G.; Wuthrick, Evan; Gregory, Kristina M.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 16, No. 4, 01.04.2018, p. 359-369.

Research output: Contribution to journalComment/debate

Benson, AB, Venook, AP, Al-Hawary, MM, Cederquist, L, Chen, YJ, Ciombor, KK, Cohen, S, Cooper, HS, Deming, D, Engstrom, PF, Garrido-Laguna, I, Grem, JL, Grothey, A, Hochster, HS, Hoffe, S, Hunt, S, Kamel, A, Kirilcuk, N, Krishnamurthi, S, Messersmith, WA, Meyerhardt, J, Miller, ED, Mulcahy, MF, Murphy, JD, Nurkin, S, Saltz, L, Sharma, S, Shibata, D, Skibber, JM, Sofocleous, CT, Stoffel, EM, Stotsky-Himelfarb, E, Willett, CG, Wuthrick, E, Gregory, KM & Freedman-Cass, DA 2018, ' NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 4, pp. 359-369. https://doi.org/10.6004/jnccn.2018.0021
Benson, Al B. ; Venook, Alan P. ; Al-Hawary, Mahmoud M. ; Cederquist, Lynette ; Chen, Yi Jen ; Ciombor, Kristen K. ; Cohen, Stacey ; Cooper, Harry S. ; Deming, Dustin ; Engstrom, Paul F. ; Garrido-Laguna, Ignacio ; Grem, Jean L. ; Grothey, Axel ; Hochster, Howard S. ; Hoffe, Sarah ; Hunt, Steven ; Kamel, Ahmed ; Kirilcuk, Natalie ; Krishnamurthi, Smitha ; Messersmith, Wells A. ; Meyerhardt, Jeffrey ; Miller, Eric D. ; Mulcahy, Mary F. ; Murphy, James D. ; Nurkin, Steven ; Saltz, Leonard ; Sharma, Sunil ; Shibata, David ; Skibber, John M. ; Sofocleous, Constantinos T. ; Stoffel, Elena M. ; Stotsky-Himelfarb, Eden ; Willett, Christopher G. ; Wuthrick, Evan ; Gregory, Kristina M. ; Freedman-Cass, Deborah A. / NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines In: JNCCN Journal of the National Comprehensive Cancer Network. 2018 ; Vol. 16, No. 4. pp. 359-369.
@article{a4a120e2ae50442b8ba017548e4c4135,
title = "NCCN Guidelines {\circledR} Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines",
abstract = "The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.",
author = "Benson, {Al B.} and Venook, {Alan P.} and Al-Hawary, {Mahmoud M.} and Lynette Cederquist and Chen, {Yi Jen} and Ciombor, {Kristen K.} and Stacey Cohen and Cooper, {Harry S.} and Dustin Deming and Engstrom, {Paul F.} and Ignacio Garrido-Laguna and Grem, {Jean L.} and Axel Grothey and Hochster, {Howard S.} and Sarah Hoffe and Steven Hunt and Ahmed Kamel and Natalie Kirilcuk and Smitha Krishnamurthi and Messersmith, {Wells A.} and Jeffrey Meyerhardt and Miller, {Eric D.} and Mulcahy, {Mary F.} and Murphy, {James D.} and Steven Nurkin and Leonard Saltz and Sunil Sharma and David Shibata and Skibber, {John M.} and Sofocleous, {Constantinos T.} and Stoffel, {Elena M.} and Eden Stotsky-Himelfarb and Willett, {Christopher G.} and Evan Wuthrick and Gregory, {Kristina M.} and Freedman-Cass, {Deborah A.}",
year = "2018",
month = "4",
day = "1",
doi = "10.6004/jnccn.2018.0021",
language = "English (US)",
volume = "16",
pages = "359--369",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

AU - Benson, Al B.

AU - Venook, Alan P.

AU - Al-Hawary, Mahmoud M.

AU - Cederquist, Lynette

AU - Chen, Yi Jen

AU - Ciombor, Kristen K.

AU - Cohen, Stacey

AU - Cooper, Harry S.

AU - Deming, Dustin

AU - Engstrom, Paul F.

AU - Garrido-Laguna, Ignacio

AU - Grem, Jean L.

AU - Grothey, Axel

AU - Hochster, Howard S.

AU - Hoffe, Sarah

AU - Hunt, Steven

AU - Kamel, Ahmed

AU - Kirilcuk, Natalie

AU - Krishnamurthi, Smitha

AU - Messersmith, Wells A.

AU - Meyerhardt, Jeffrey

AU - Miller, Eric D.

AU - Mulcahy, Mary F.

AU - Murphy, James D.

AU - Nurkin, Steven

AU - Saltz, Leonard

AU - Sharma, Sunil

AU - Shibata, David

AU - Skibber, John M.

AU - Sofocleous, Constantinos T.

AU - Stoffel, Elena M.

AU - Stotsky-Himelfarb, Eden

AU - Willett, Christopher G.

AU - Wuthrick, Evan

AU - Gregory, Kristina M.

AU - Freedman-Cass, Deborah A.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.

AB - The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.

UR - http://www.scopus.com/inward/record.url?scp=85045662724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045662724&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0021

DO - 10.6004/jnccn.2018.0021

M3 - Comment/debate

VL - 16

SP - 359

EP - 369

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -